PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

PerkinElmer Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. ET.

Steve Willoughby, senior vice president, investor relations & head of ESG, and Alan Fletcher, senior vice president, Life Sciences, will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer Investor Relations website after the event and will be available for at least 30 days.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $4.6 billion in 2022, has more than 16,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  199.99
+0.39 (0.20%)
AAPL  259.14
-2.59 (-0.99%)
AMD  208.90
+2.96 (1.44%)
BAC  52.63
+0.11 (0.21%)
GOOG  306.94
-2.43 (-0.79%)
META  649.42
-0.39 (-0.06%)
MSFT  403.43
+1.59 (0.40%)
NVDA  184.01
-2.93 (-1.57%)
ORCL  160.35
+3.88 (2.48%)
TSLA  420.26
+3.19 (0.77%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.